Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 45,000 shares at $15.02 ($225K) on 2012-03-20, disclosed to the SEC on 2012-03-21.
Open-market sale of $225k ARIA by SVP, Clinical R&D, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 30,000 | $0 | 0.0% |
| 2 | $15.02 | 15,000 | $225K | 100.0% |
| Total | $5.01 avg | 45,000 | $225K | 100% |
| Filing → |
| ARIA | SELL | 2016-02-03 | $155K | — | Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |